Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq National Market (the "Nasdaq Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market.
Appears in 1 contract
Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The the Nasdaq National Market (the "Nasdaq Stock Capital Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from the Nasdaq Stock Capital Market, nor has the Company received any notification that the SEC, the Financial Industry Regulatory Authority, Inc. (“FINRA”), or Nasdaq is contemplating terminating such registration or listing, except to the extent that the Company has resolved the issues raised in any such notification.
Appears in 1 contract
Sources: Stock and Warrant Purchase Agreement (Inhibitex, Inc.)
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), ) and is listed quoted on The the Nasdaq National Market OTC Bulletin Board (the "Nasdaq Stock MarketBulletin Board"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting removing the Common Stock from the Nasdaq Stock MarketBulletin Board.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange 1934 Act of 1934, as amended (the "Exchange Act"), and is listed on The the Nasdaq National Capital Market (the "Nasdaq Stock Market"“Nasdaq”), and the Company has taken no action designed tonot received any notification that the Commission, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Marketor the Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or listing.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g12(b) of the Securities Exchange 1934 Act of 1934, as amended (the "Exchange Act"), and is listed on The the Nasdaq National Capital Market (the "Nasdaq Stock Market"“Nasdaq”), and the Company has taken no action designed tonot received any notification that the Commission, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Marketor the Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or listing.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq Stock National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from the Nasdaq Stock National Market., nor has the
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq National Market (the "Nasdaq Stock MarketNASDAQ STOCK MARKET"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq National Market (the "Nasdaq Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Market.
Appears in 1 contract
Sources: Securities Purchase Agreement (Napro Biotherapeutics Inc)
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq National Market (the "Nasdaq Stock Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from the Nasdaq Stock Market.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq National Market (the "Nasdaq Stock Market"). The Company has not, and in the twelve (12) months preceding the Effective Date hereof, received written notice from the Nasdaq Stock Market that the Company has taken no action designed to, is not in compliance with the listing or likely to have the effect of, terminating the registration maintenance requirements of the Common Nasdaq Stock under Market. The issuance and sale of Shares hereunder does not contravene the Exchange Act or delisting the Common Stock from rules and regulations of the Nasdaq Stock Market.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq Stock National Market"), . The Company is currently in full compliance with Nasdaq requirements and the Company has taken no will not take any action designed to, or likely which will cause it to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Stock Marketfail to comply.
Appears in 1 contract
Sources: Series a Convertible Preferred Stock Purchase Agreement (Fastnet Corp)